Overview Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel Status: Completed Trial end date: 2016-11-01 Target enrollment: Participant gender: Summary Study designed to assess the safety and plasma PK of tretinoin and its metabolites from topically applied IDP-120 gel. Phase: Phase 1 Details Lead Sponsor: Bausch Health Americas, Inc.Valeant Pharmaceuticals International, Inc.